APLS vs TAP
Apellis Pharmaceuticals Inc (APLS) versus TAP (TAP) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
TAP (TAP) common stock.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
TAP does not have a complete income-statement cache yet.
APLS currently screens at market cap $2.29B. TAP currently screens at market cap $0.
Not investment advice. Open the APLS and TAP stock pages for the full models.
Not investment advice.